Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2018

Feb 14, 2019

SELL
$32.0 - $47.43 $1.6 Million - $2.37 Million
-50,000 Closed
0 $0
Q3 2018

Feb 11, 2021

BUY
$47.1 - $62.7 $2.33 Million - $3.1 Million
49,500 Added 9900.0%
50,000 $2.36 Million
Q3 2018

Nov 14, 2018

BUY
$47.1 - $62.7 $23,550 - $31,350
500 New
500 $280,000

Others Institutions Holding MRTX

About Mirati Therapeutics, Inc.


  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.